Short interest in Revance Therapeutics Inc (NASDAQ:RVNC) increased during the last reporting period, rising from 12.21M to 12.70M. This put 13.89% of the company's publicly available shares short.

Short interest for Revance Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Revance Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.67M shares traded per day, it would take 7.62 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.